Clinical Study

Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients’ Survival

Table 4

Median sCD30 levels according to initial graft function and presence of acute rejection and early pyelonephritis.

Groups of patientsnPretransplant sCD30Posttransplant sCD30 value

Initial graft function
 IGF2051.3 (34.5–70.6)21.3 (14.6–41.3)
 SGF527.3 (21.7–36.9)19.9 (11.7–23.1)
 DGF853.5 (39.7–72.9)32.8 (25.7–39.9)
Acute rejection
 Without AR2346.6 (30.8–70.6)26.6 (12.4–40.1)
 AR at any time1147.1 (36.9–60.2)21.3 (15.7–34.0)
 Very early AR (0–7th day)556.1 (51.0–60.2)21.2 (15.7–55.2)
 Early AR (the 8th day–6 months)360.2 (43.3–70.7)23.5 (21.4–56.7)
 Late AR (>6 months)336.9 (17.1–40.9)16.1 (9.2–34.0)
Early pyelonephritis (the 8th
day–2 months)
 No2949.5 (36.9–64.2)26.6 (15.8–40.1)
 Yes424.5 (16.7–49.0)16.5 (11.2–22.2)

sCD30: soluble CD30; IGF: immediate graft function; SGF: slow graft function; DGF: delayed graft function; AR: acute rejection; n: number of patients investigated. Median (interquartile range).